Data collection and audit is fundamental to providing evidence of best prescribing practice. New therapies such as biologics in immunology and oncology are very effective but expensive. Organisations like the National Institute for Health and Clinical Excellence (NICE) in the UK are needed to provide guidelines on prescribing practice to 'control' the use of these drugs.

Those guidelines include the use of internationally recognised disease scoring systems and audit parameters which clinicians should use. However, data collection in secondary care focuses more on management and finance outcomes than clinical.

THERAPYAUDIT® plugs that gap, providing clinicians with an audit capability which in turn helps pharmaceutical companies to achieve their objectives of proving effectiveness and providing post-launch safety.

THERAPYAUDIT Products

	TAMonitor™ monitors electronic copy of blood results for toxic drug reactions (read more...)
	TAScoring™ collects and audits disease assessment scores (read more...)
	TATouch™ enables patients to complete patient-centric forms (read more...)

Need more information?

Call +44 (0)800 756 1087

             click here to try TAMonitor for yourself!